Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve and take ....
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Kidney and Super Speciality Ltd has informed BSE that its Board of Directors meeting, originally scheduled for Friday, February 13, 2026, has been postponed to Saturday, February 14, 2026 due to unavoidable circumstances. The meeting will, among other things, consider and approve the Un-Audited standalone and consolidated Financial Results of the Company for the quarter ended December 31, 2025 (Q3 FY26). The trading window for designated persons remains closed since January 1, 2026 and will reopen 48 hours after the results are made public, as per SEBI insider trading rules.
This is a routine procedural filing with no material financial impact. Investors should watch for the Q3 FY26 results announcement on or after February 14, 2026, which will provide insight into the company's financial performance.